Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- Mindray Medical International (NYSE: MR) hit a new 52-week high Tuesday as it is currently trading at $39.78, above its previous 52-week high of $39.43 with 412,401 shares traded as of 3:41 p.m. ET. Average volume has been 786,400 shares over the past 30 days. Mindray Medical International has a market cap of $4.59 billion and is part of the health care sector and health services industry. Shares are up 20.2% year to date as of the close of trading on Monday. Mindray Medical International Limited, through its subsidiary, Shenzhen Mindray, develops, manufactures, and markets medical devices worldwide. It operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. The company has a P/E ratio of 21.7, above the S&P 500 P/E ratio of 17.7.